Dr Anna Bergström, PhD, MSc Epidemiology
Public Health Researcher
Dr Anna Bergström reads the methods section first and the abstract last, a habit she picked up in an epidemiology department and has never seen a good reason to drop. In most fields the two agree. In this one they frequently do not, and the gap between what a study did and what its summary says it showed is where nearly every misleading claim about the arts and health begins.
She is a public health researcher with a PhD and an MSc in epidemiology, and her work is in evaluation methods rather than in the arts. She came to this site through the back door: not as an enthusiast for creative health, but as somebody who kept encountering the same handful of figures in policy documents and could not find the studies underneath them. Her role here is deliberately narrow and, on a site like this one, load bearing. She checks the arithmetic.
In practice that means she goes through every efficacy claim on the site and confirms that the design, the sample size, the effect size, the confidence interval and the certainty rating are described as the source describes them, in the source’s own units. She is the reason a gait speed result is quoted in metres per minute here rather than converted into a livelier looking number, the reason a nested count of studies inside reviews is not flattened into two impressive figures side by side, and the reason a subgroup finding at one timepoint is never reported as a whole sample result. Her hardest rule is also the simplest: an uncontrolled before and after evaluation is not a trial, is never called one on this site, and does not become one by being cited in a government report.
She owns the three tier claim ladder set out in the editorial policy and signs off the pages where the evidence is weakest or most contested, including the methods explainer that the rest of the site links to.
The point she asks to have made whenever the tiers are explained is the one most easily lost. “No adequately powered controlled evidence” and “it does not work” are different statements, and treating them as the same is a mistake in the opposite direction from the one this site usually corrects. A Tier 3 label means the question has not been answered properly yet. Plenty of things people find genuinely valuable sit there, and some of them will move up when somebody finally runs the study.
Articles reviewed by Dr Anna Bergström
- Art Therapy During Cancer Treatment: Use, Access and the Certainty Problem
- Art Therapy for Trauma and PTSD: What the Controlled Evidence Supports
- Art Therapy for Psychosis: The MATISSE Trial and Why Services Still Offer It
- Arts for Carers and Health Staff: Enthusiasm Running Well Ahead of the Evidence
- Creative Health Policy and Reports: What They Are For, and Why They Are Not Evidence
- Creative Activity in Dementia Care: What the 2025 Review Changed, and What to Expect
- Dance After Stroke: Feasibility Studies, Small Samples and What Would Need to Be Shown
- Dance, Balance and Falls: A Physical Outcome, and Why That Changes the Argument
- Dance for Depression: The Mislabelled Effect Size, and What the Review Actually Reports
- Dance for Parkinson's: The Best Supported Corner of Dance Research, and What That Means
- Does Arts on Prescription Save Money? Following the £216 Back to Its Arithmetic
- Does Hospital Art Speed Recovery? One 1984 Study, Read Line by Line
- Movement and Multiple Sclerosis: Fatigue, Balance and the Limits of the Current Work
- Music Therapy for Dementia: What the 2025 Cochrane Review Actually Found
- Music Therapy for Autistic Children: Outcome Measures and the Framing Argument
- Music Therapy for Depression and Anxiety in Adults: Where the Evidence Sits
- Music Before Surgery: An Unusually Clean Result on an Unusually Soft Outcome
- Reading Arts in Health Research: Effect Sizes, Certainty and Where a Figure Came From
- Rhythmic Auditory Stimulation: The Strongest Evidence in Arts and Health
- Singing for Lung Health: An Unusually Well Defined Intervention Without a Locked Figure
- Tango and Parkinson's Research: How a Small Striking Finding Becomes a Global Claim